Tiger Jade Capital

Overview

Tiger Jade Capital is a private equity firm established in 2019, specializing in the global healthcare industry. The firm focuses on investments in new pharmaceuticals, contract research organizations (CROs), medical equipment, and related sectors. Its mission is to enhance public well-being by supporting innovative healthcare technologies and services. The firm's investment strategy is centered on early-stage to growth-stage companies, with a particular emphasis on buyouts. Tiger Jade Capital is strategically positioned in China, where medical expenses constitute 6.2% of the GDP, presenting significant growth opportunities. The development of commercial insurance and the inclusion of innovative drugs in the national healthcare system further accelerate the potential for healthcare innovations. Tiger Jade Capital's team comprises professionals with extensive experience in private equity and healthcare sectors. The firm is uniquely positioned to access top deals in the healthcare area, leveraging its association with Tigermed as a lead cornerstone investor. This partnership provides exclusivity to premier healthcare investments and facilitates collaboration with other resources and industry funds aggregated by Tigermed. The firm's commitment to integrity and community contribution is evident in its pledge to donate 5% of its general partner management fee profit and carry income to charities supporting underprivileged groups.

Investment Focus

• Innovative healthcare technologies
• Experienced management teams
• Scalable business models
• Strong growth potential

Portfolio Companies